Evidence map›Paper›PMID 40456874›Full record

ArticleScientific reports2025

Isotopic imaging with epithermal neutrons at the ISIS Neutron and Muon Source.

Giulia Marcucci, Antonella Scherillo, Davide Raspino, Daniela Di Martino

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Giulia MarcucciSTFC ISIS Neutron and Muon Source, Rutherford Appleton Laboratory, Didctot, UK.
Antonella ScherilloSTFC ISIS Neutron and Muon Source, Rutherford Appleton Laboratory, Didctot, UK. Antonella.Scherillo@stfc.ac.uk.
Davide RaspinoSTFC ISIS Neutron and Muon Source, Rutherford Appleton Laboratory, Didctot, UK.
Daniela Di MartinoDipartimento di Fisica "G. Occhialini", Università degli Studi di Milano-Bicocca and INFN Sezione di Milano-Bicocca, Milano, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An advanced non-invasive isotopic imaging technique based on Neutron Resonance Transmission Imaging (NRTI) has been implemented at the INES beamline of the ISIS Neutron Muon Source (UK), featuring high sensitivity to isotopes and enabling enhanced contrast in bulk radiography. NRTI relies on the neutron resonant absorption reactions occurring at epithermal energies. Nuclear resonance energies are isotope fingerprints, since the energy position of resonance dips in the transmitted neutron spectrum is uniquely associated with the individual isotopes present in the sample. Using a time and space-resolved detector with an event-mode acquisition system it is possible to conduct simultaneous spectroscopy and imaging investigation by recording the transmitted spectra in each pixel. Resonance selections can be performed post-processing through specific data analysis tools to enhance the absorption contrast of selected isotopes and visualise their distribution in the bulk. A pilot study with samples enriched with Ag-109 and Ag-107 is presented to demonstrate the potential of NRTI at the ISIS facility as a powerful and competitive tool for isotopic imaging. Future quantitative calibration for accurate isotopic ratio evaluation will expand its utility across various fields, such as nuclear engineering and archaeology, enabling detailed non-invasive analysis of complex materials previously challenging with conventional methods.

Indexed as

Contrast enhancementEpithermal neutronsIsotopic imagingNeutron imagingNuclear resonancesSilver isotopes

Identifiers

PMID40456874
PMCPMC12130481

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.